BFI CO., LLC sold 40.0% of their position (12K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $568.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/27/2018ACC: 0001144204-18-040561
-12K
Net shares
Net seller
$568.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
12K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
−4K
Price / share
$47.37
Trade value
$189.48K
% of position
13.3%
7/25/2018
30K→26K
Class A Common Stock
Direct
Shares
−4K
Price / share
$47.61
Trade value
$190.44K
% of position
15.4%
7/26/2018
26K→22K
Class A Common Stock
Direct
Shares
−4K
Price / share
$47.07
Trade value
$188.28K
% of position
18.2%
7/27/2018
22K→18K
Total
Net shares
−12K
Net value
-$568.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/25/2018 | S · Sale | −4K | $47.37 | $189.48K | 13.3% | 30K | 26K |
| Class A Common Stock Direct | 7/26/2018 | S · Sale | −4K | $47.61 | $190.44K | 15.4% | 26K | 22K |
| Class A Common Stock Direct | 7/27/2018 | S · Sale | −4K | $47.07 | $188.28K | 18.2% | 22K | 18K |
| Total | −12K | -$568.20K | ||||||
Derivative Transactions0
No derivative transactions reported